Trubion Logo
  • ABOUT
    • Company Overview
    • Management
    • Contact Information
  • PRODUCTS
    • Product Strategy
    • Product Candidates
    • TRU-015 (Rheumatoid Arthritis)
    • SBI-087 (Rheumatoid Arthritis)
    • SBI-087 (Systemic Lupus Erythematosus)
    • TRU-016 (B-Cell Malignancies)
    • Product Technology
    • SMIP™ Therapeutics
    • SCORPION™ Therapeutics
    • TRU-ADhanCe™ Technology
    • Patient Center
    • Rheumatoid Arthritis (RA)
    • Leukemia
    • Lymphoma
    • Lupus
  • PARTNERSHIPS
    • Current Partnerships
  • INVESTORS
    • Corporate Governance
    • Stock Information
    • Stock Performance
    • Historic Stock Lookup
    • Investment Calculator
    • Dividend History
    • Analyst Coverage
    • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
    • News & Events
    • Press Releases
    • Events & Presentations
    • Stockholder Services
    • Investor FAQs
    • Contact Us
  • MEDIA
  • CAREERS
    • Joining the Trubion Team
    • Job Openings
    • Culture and Benefits

Press Releases

Print Print page     Email Email page

All 2010 Releases
Trubion Provides Update on Clinical Development in RA
Jun 14, 2010
PDF Add to Briefcase
Trubion Pharmaceuticals Wins Genentech and Biogen Idec Patent Appeal
Jun 3, 2010
PDF Add to Briefcase
Trubion Pharmaceuticals, Inc. to Present at 9th Annual Needham Healthcare Conference
Jun 1, 2010
PDF Add to Briefcase
Trubion Pharmaceuticals, Inc. Announces Acceptance of Two Presentations on Its SBI-087 Product Candidate at EULAR 2010
May 12, 2010
PDF Add to Briefcase
Trubion Pharmaceuticals, Inc. Reports First-Quarter 2010 Financial Results
May 6, 2010
PDF Add to Briefcase
Trubion Announces Dates for First-Quarter 2010 Earnings Conference Call
Apr 29, 2010
PDF Add to Briefcase
Trubion Pharmaceuticals, Inc. to Present at the BioCentury and Thomson Reuters Future Leaders in the Biotech Industry Conference
Apr 5, 2010
PDF Add to Briefcase
Trubion Pharmaceuticals, Inc. Reports Fourth-Quarter and Year-Ended 2009 Financial Results
Mar 15, 2010
PDF Add to Briefcase
Trubion Announces Dates for Fourth-Quarter and Year-Ended 2009 Earnings Conference Call
Mar 8, 2010
PDF Add to Briefcase
Trubion Pharmaceuticals, Inc. Announces Initiation of a Phase 2 Study of SBI-087 for the Treatment of Rheumatoid Arthritis (RA)
Jan 11, 2010
PDF Add to Briefcase
Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at OneMedForum 2010
Jan 6, 2010
PDF Add to Briefcase
Showing 1-11 of 11 releases

Shareholder Tools

  • Briefcase Shareholder Briefcase
  • Printed Materials Virtual Investor Kit
  • Email Alerts Email Alerts
  • Download Center Download Library
  • RSS RSS News Feeds

  • Search Investor Relations


Copyright 2002–2008 Trubion Pharmaceuticals Inc. All rights reserved.

Site Map | Terms of Use